Logo image of AKBA

AKEBIA THERAPEUTICS INC (AKBA) Stock Analyst Ratings

NASDAQ:AKBA - Nasdaq - US00972D1054 - Common Stock - Currency: USD

2.45  +0.06 (+2.51%)

After market: 2.43 -0.02 (-0.82%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to AKBA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.52. This target is 207.04% above the current price.
AKBA was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about AKBA.
In the previous month the buy percentage consensus was at a similar level.
AKBA was analyzed by 10 analysts. More opinions would make the average more meaningful.
AKBA Historical Analyst RatingsAKBA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 5 10 15

Price Target & Forecast

Price Low Median Mean High 2.456.066.897.5210.50 - 147.35% 181.02% 207.04% 328.57%
AKBA Current Analyst RatingAKBA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-04-28 Leerink Partners Initiate Outperform
2025-04-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-01 Jefferies Initiate Buy
2025-03-14 Piper Sandler Maintains Overweight -> Overweight
2025-03-14 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-23 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-28 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-17 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-27 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-28 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-08-11 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-06-21 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-06-14 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-06-02 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-31 Piper Sandler Upgrade Neutral -> Overweight
2023-05-30 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-26 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-09 Needham Reiterate Neutral
2023-04-26 HC Wainwright & Co. Maintains Neutral
2023-03-31 HC Wainwright & Co. Reiterate Neutral
2023-03-10 HC Wainwright & Co. Reiterate Neutral
2023-02-22 HC Wainwright & Co. Maintains Neutral
2022-05-16 HC Wainwright & Co. Maintains Neutral